{
    "clinical_study": {
        "@rank": "141228", 
        "arm_group": [
            {
                "arm_group_label": "ASP7147", 
                "arm_group_type": "Experimental", 
                "description": "ASP7147, 300 mg, tablet, twice per day for 4 weeks oral"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "oral"
            }
        ], 
        "brief_summary": {
            "textblock": "This trial will evaluate the effect of ASP7147 on daily abdominal pain due to IBS-D during 4\n      weeks of treatment. It will also evaluate safety and tolerability in patients with IBS-D\n      over the 4-week treatment period."
        }, 
        "brief_title": "A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)", 
        "condition": "Diarrhea Predominant Irritable Bowel Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Diarrhea", 
                "Irritable Bowel Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ability to provide written informed consent\n\n          -  Men or women aged 18-75 years\n\n          -  Patient has IBS with diarrhea (IBS-D)\n\n          -  Ability to communicate with the investigator\n\n        Exclusion Criteria:\n\n          -  IBS with constipation (IBS-C) or mixed IBS (IBS-M)\n\n          -  Other significant disease or condition that may interfere with trial completion\n\n          -  Untreated lactose intolerance\n\n          -  History of alcohol or drug abuse in past two years\n\n          -  Participation in other clinical trials within prior month"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01896583", 
            "org_study_id": "7147-CL-0003"
        }, 
        "intervention": [
            {
                "arm_group_label": "ASP7147", 
                "description": "300 mg, tablet, twice per day for 4 weeks oral", 
                "intervention_name": "ASP7147", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "February 6, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85018"
                    }, 
                    "name": "Elite Clinical Studies"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Encino", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91436"
                    }, 
                    "name": "Shahram Jacobs, M.D., Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Mesa", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91942"
                    }, 
                    "name": "Grossmont Center for Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Ana", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92701"
                    }, 
                    "name": "Probe Clinical Research Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33015"
                    }, 
                    "name": "San Marcus Research Clinic Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33135"
                    }, 
                    "name": "Suncoast Research Group, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33709"
                    }, 
                    "name": "Meridien Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Watertown", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02472"
                    }, 
                    "name": "MedVadis Research Corporation"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63141"
                    }, 
                    "name": "Sundance Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89119"
                    }, 
                    "name": "OM Medical"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27103"
                    }, 
                    "name": "PMG Research of Winston-Salem, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43215"
                    }, 
                    "name": "Remington-Davis, Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78288"
                    }, 
                    "name": "DCT - Stone Oak, LLC dba Discovery Clinical Trials"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety and Tolerability, of ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "10-point pain scale", 
            "measure": "Abdominal pain", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01896583"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Bristol Stool Scale (7-point scale)", 
                "measure": "Stool consistency", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "Number of bowel movements per day", 
                "measure": "Stool frequency", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }
        ], 
        "source": "Seldar Pharma, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seldar Pharma, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}